Professor of Medicine, University Okla College of Medicine
Hematology
Dr. George B. Selby, MD
|
|
Give Review
George Selby practices Hematology. He attended University of Oklahoma College of Medicine. He received awards:"Oklahoma Magazine" and "Top MD". Dr. George B. Selby is a published MD. He has 46 papers published. The most current publication "G-CSF-mobilized donor leukocyte infusions as immunotherapy in acute leukemia relapsing after allogeneic marrow transplantation." He accepts all Medicare patients.
Publications
- Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case F...
- DMSO induced myocardial infarction during allogeneic cryopreserved Bone marrow transplant.
- Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.
- Catheter-related complications in patients with Acute myeloid leukemia after hematopoietic stem cell transplant.
- Autoimmune hemolytic Anemia and thrombocytopenia attributed to an intrauterine contraceptive device.
- Autologous is Superior to Allogeneic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia in Second Complete Remission.
- Pulmonary Arteriovenous Malformations Presenting as Platypnea-Orthodeoxia in Graft-Versus-Host Disease.
- Challenges and Potential Solutions for Recruitment and Retention of Hematopoietic Cell Transplantation Physicians: The National Marrow Donor Program's System Capacity ...
- Impending challenges in the hematopoietic stem cell transplantation physician workforce.
- Difficulties in monitoring the glucose status of patients undergoing hematopoietic stem cell transplantation.
- Bevacizumab in hereditary hemorrhagic telangiectasia.
- HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid Leukemia.
- Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study.
- Leukemia burden and outcome of allogeneic transplant in Acute myelogenous leukemia.
- Iron overload manifesting as apparent exacerbation of hepatic Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
- Increased mean corpuscular volume after autologous hematopoietic stem cell transplantation: incidence and significance.
- Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an Analysis of 735 grafts.
- Re: failure to enGraft after autologous stem cell transplantation: possible therapeutic role of cyclosporine.
- Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.
- Endurance swimming, intravascular hemolysis, Anemia, and iron depletion. New perspective on athlete's Anemia.
- A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study.
- Hematocrit and performance: the effect of endurance training on Blood volume.
- Introducing case management to a general medicine ward team of a teaching hospital.
- Allogeneic Bone marrow transplantation: experience with 92 patients.
- A case of Acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?
- Marrow and stem cell transplantation in Oklahoma: fifteen years of experience and results.
- The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML.
- Autologous bone marrow transplantation for metastatic breast Cancer.
- Cytomegalovirus surveillance and prevention in allogeneic Bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy.
- Long-term survival after autologous bone marrow transplantation for metastatic Breast carcinoma.
- Long-term results of autologous Marrow transplantation for relapsed or refractory male or female germ cell tumors.
- Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral Blood progenitor cell and bone marrow transplantation.
- Autologous bone marrow transplantation for non-Hodgkin Lymphoma.
- High-dose carboplatin, etoposide and cyclophosphamide with autologous Bone marrow transplantation for the treatment of advanced malignancies: a phase I study.
- G-CSF-mobilized donor leukocyte infusions as immunotherapy in Acute leukemia relapsing after allogeneic marrow transplantation.
- Routine chest radiography for the evaluation of febrile neutropenic patients after autologous stem cell transplantation.
- Thrombotic microangiopathy after allogeneic Bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes.
- Expression of the vascular endothelial growth factor receptors 1 and 2 in Acute myeloid leukemia: incidence and feasibility of immunohistochemical staining.
- Formation of fibrin clots in cryopreserved stem cell bags during thawing procedure: lack of impact on enGraftment in autologous stem cell transplantation.
- Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and Graft-versus-host disease.
- High-dose combination alkylating agent therapy with autologous Bone marrow rescue for refractory solid tumors.
- Role of intra-arterial steroid administration in the management of steroid-refractory Acute gastrointestinal graft-versus-host disease.
- Denileukin diftitox for the treatment of steroid-resistant Acute graft-versus-host disease.
- Successful autologous stem-cell transplantation after 21 years of cryopreservation.
- Delayed Myeloid engraftment due to vancomycin in allogeneic haematopoietic stem cell transplant recipients.
Schools
University Of Oklahoma College Of Medicine
Okla Tchg Hosps
Oklahoma City University
Procedures Preformed
- Bone Marrow Aspiration
- Bone Marrow Transplant
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- View All
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Aplastic Anemia
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- Oklahoma Magazine
- Top MD
Education
-
University of Oklahoma Health Sciences Center -
University of Oklahoma College of Medicine
Drug Facts
| NPI NUMBER | 1679542963 | |
| NPPES Provider LastName | SELBY | |
| NPPES Provider FirstName | GEORGE | |
| NPPES Provider ZIPCode | 731045417 | |
| NPPES Provider State | OK | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 511.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 32.0 | |
| Percent Opioid Claims | 6.26 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679542963 |
| Last Name Of The Provider | SELBY |
| First Name Of The Provider | GEORGE |
| View All |
Similar Doctors
|
Dr. Gregory A. Parker, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Keefer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James N. George, MD |
|
Dr. Johnny R. McMinn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William F. Kern III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamad O. Khawandanah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert B. Epstein, MD |
|
|
Dr. Wajeeha Razaq, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ritesh Parajuli, MD
This Doctor is OpenDoctor Recommended.
|